SOLARA ACTIVE PHARMA SCIENCES LIMITED — Board/Management Information 2022

Mar 14, 2022

==> picture [59 x 54] intentionally omitted <==

==> picture [122 x 36] intentionally omitted <==

==> picture [59 x 54] intentionally omitted <==

==> picture [87 x 9] intentionally omitted <==

NameofKeyManagerialPersonnelIMr.S.Hariharan	NameofKeyManagerialPersonnelIMr.S.Hariharan
Reason for change, viz,appointmentConsequenttothe resignationofMrSubhash Chand AnandasExecutive Director andCFOofthe Company, the BoardofDirectorsofthe Company, pursuanttothe recommendationbythe Nomination and Remuneration Committee and AuditCommittee, approved the appointmentofMr.S.HariharanasExecutive Director and Chief Financial Officer(CFO)oftheCompany.Theappointmentissubjecttothe approvalofshareholdersofthe Company, which shall be soughtseparately.
Dateofappointment	The appointmentiseffective from March9, 2022.
TermofAppointment	Threeyears
Brief profile	Hariharan1sa Cost Accountant with rich and variedexperienceofmore than 30 years in fieldofCorporateFinance, Accounts and Strategic planning.Heplayed a veryimportant role in the merger processofShasunwith Stridesduring2014and2015.Also in demerger processofStrides,SeQuent and Solara during2017and2018.Hehas richexperience in the fieldsofFinance, Accounts, Secretarial,Taxation, Legal and Information Technology functions.Hehasextensive experience in Mergers and Acquisitions.
Disclosureofrelationshipbetween directors	Mr.S.Hariharanisnotrelatedtoany DirectoroftheCompany.